Masashi Murata

Title: Masashi Murata: Innovator in Gene Therapy

Introduction

Masashi Murata is a prominent inventor based in Toyonaka, Japan. He has made significant contributions to the field of gene therapy, particularly through his innovative work on adenovirus vectors. With a total of 2 patents, Murata's inventions aim to enhance the efficacy and safety of gene therapy treatments.

Latest Patents

Murata's latest patents focus on a recombinant adenovirus vector designed to reduce side effects during in vivo administration. The first patent presents a novel adenovirus vector that alleviates inflammation by inhibiting the expression of an adenovirus gene through a foreign promoter inserted into the adenovirus genome. This invention also includes methods for producing the vector, a cell line for its production, and a gene therapy method utilizing the recombinant adenovirus vector.

Career Highlights

Masashi Murata is associated with Dainippon Sumitomo Pharma Co., Ltd., where he continues to advance his research in gene therapy. His work has garnered attention for its potential to improve patient outcomes in gene therapy applications.

Collaborations

Murata collaborates with notable colleagues, including Michio Nakai and Kazuo Komiya, who contribute to his research endeavors and innovations in the field.

Conclusion

Masashi Murata's contributions to gene therapy through his innovative adenovirus vectors highlight his role as a key inventor in the field. His work not only addresses critical challenges in gene therapy but also paves the way for future advancements in medical treatments.